Long-Term follow-Up and management patterns of patients with Acute Coronary Syndrome in Middle East and Africa

Trial Identifier:	D1843R00256
Sponsor:	AstraZeneca
NCTID::	NCT03362463
Start Date:	December 2015
Primary Completion Date:	April 2020
Study Completion Date:	April 2020

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Qatar	Doha, Qatar

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.